Maverick Capital’s Nu Skin NUS Stock Holding History

Maverick Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-61,250	Closed	-$3.02M	–	383
2019 Q2	$3.02M	Sell	61,250 -6,600	-10%	-$336K	0.04%	210
2019 Q1	$3.25M	Buy	67,850 +16,640	+32%	+$1.01M	0.04%	223
2018 Q4	$3.14M	Buy	+51,210	New	+$3.45M	0.05%	221

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Maverick Capital's NUS Position: Q3 2019 in Review

Maverick Capital sold out of Nu Skin (NUS) in Q3 2019, closing a stake of 61,250 shares — an estimated $3.02M sold.

Maverick Capital first reported a position in NUS in Q4 2018 and held it in 3 quarters. The position peaked at $3.25M in Q1 2019. 235 funds tracked by Wall St. Rank hold NUS as of Q3 2019.

Maverick Capital reported no remaining Nu Skin position as of Q3 2019 after selling out during the quarter.
Maverick Capital sold 61,250 Nu Skin shares in Q3 2019, an estimated $3.02M.
Maverick Capital first reported a position in Nu Skin in Q4 2018 and held it in 3 quarters.
Maverick Capital's Nu Skin position peaked at $3.25M in Q1 2019.
235 funds tracked by Wall St. Rank held Nu Skin as of Q3 2019.

Based on Maverick Capital's 13F filing for Q3 2019, filed 14 Nov 2019.